Ayr Wellness Inc. (AYR-A.CN)
| Previous Close | 1.7100 |
| Open | 1.7500 |
| Bid | 1.6700 x N/A |
| Ask | 1.7000 x N/A |
| Day's Range | 1.6300 - 1.7500 |
| 52 Week Range | 1.6000 - 23.2800 |
| Volume | |
| Avg. Volume | 150,693 |
| Market Cap | 112.631M |
| Beta (5Y Monthly) | 1.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Should You Buy Ayr Wellness (AYRWF) Ahead of Earnings?
Ayr Wellness (AYRWF) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
Ayr Wellness Inc. (AYRWF) Expected to Beat Earnings Estimates: Should You Buy?
Ayr Wellness Inc. (AYRWF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Boston Beer announced the launch of a new line of cannabis-infused iced teas. Decibel reported rising revenue in Q1. Ayr Wellness reported positive revenue of $111.2 million, up 90% YoY. Key Takeaways; Psychedelic Sector Awakn filed PCT application for the treatment of behavioral addictions. The FDA gave Revive Therapeutics positive feedback […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclusive.
